×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Cardio-facio-cutaneous syndrome
0.570
Biomarker
CTD_human
Cardiofaciocutaneous (CFC) syndrome associated with muscular coenzyme Q10 deficiency.
17703371
2007
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Thyroid carcinoma
0.560
Biomarker
CTD_human
Agent-specific ras oncogene activation in rat thyroid tumours.
3078959
1988
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Carcinoma, Transitional Cell
0.530
Biomarker
CTD_human
Enhanced expression of Harvey-ras oncogene in FANFT-induced transitional cell carcinoma.
3433577
1987
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Glioma
0.520
Biomarker
CTD_human
Ras-Induced miR-146a and 193a Target Jmjd6 to Regulate Melanoma Progression.
30619488
2018
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Mammary Neoplasms, Experimental
0.500
Biomarker
CTD_human
Infrequent mutation of Ha-ras and p53 in rat mammary carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
8185828
1994
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Mammary Neoplasms, Experimental
0.500
Biomarker
CTD_human
High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis.
11376698
2001
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Mouth Neoplasms
0.500
Biomarker
CTD_human
Common oncogenic mutations are infrequent in oral squamous cell carcinoma of Asian origin.
24224046
2013
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Papilloma
0.500
Biomarker
CTD_human
Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene.
8330346
1993
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Adenocarcinoma of lung (disorder)
0.500
Biomarker
CTD_human
Gene expression analysis in the lung of the rasH2 transgenic mouse at week 4 prior to induction of malignant tumor formation by urethane and N-methylolacrylamide.
26558449
2015
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Malignant Glioma
0.500
Biomarker
CTD_human
Ras-Induced miR-146a and 193a Target Jmjd6 to Regulate Melanoma Progression.
30619488
2018
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Liver carcinoma
0.500
Biomarker
CTD_human
At week 16, rats that had received the mutated Ha-ras antisense oligonucleotides had significantly fewer and smaller preneoplastic lesions positive for glutathione-S-transferase, placental type, and had smaller hepatocellular carcinomas than rats that had received the sense oligonucleotide.
9311599
1997
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Liver carcinoma
0.500
Biomarker
CTD_human
Wnt/beta-catenin signaling activates and determines hepatic zonal expression of glutathione S-transferases in mouse liver.
20118494
2010
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Liver carcinoma
0.500
Biomarker
CTD_human
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
28284560
2017
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Liver carcinoma
0.500
Biomarker
CTD_human
Peroxiredoxin I is important for cancer-cell survival in Ras-induced hepatic tumorigenesis.
27517622
2016
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Liver carcinoma
0.500
Biomarker
CTD_human
Low frequency of H-ras mutations in hepatocellular adenomas and carcinomas and in hepatoblastomas from B6C3F1 mice exposed to oxazepam in the diet.
8200073
1994
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Thyroid Neoplasm
0.460
Biomarker
CTD_human
Agent-specific ras oncogene activation in rat thyroid tumours.
3078959
1988
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Mammary Neoplasms
0.450
Biomarker
CTD_human
Possible application of human c-Ha-ras proto-oncogene transgenic rats in a medium-term bioassay model for carcinogens.
17474063
2007
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Mammary Neoplasms
0.450
Biomarker
CTD_human
Increased H-ras mutation frequency in mammary tumors of rats initiated with N-methyl-N-nitrosourea (MNU) and treated with acrylamide.
19652463
2009
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Mammary Neoplasms
0.450
Biomarker
CTD_human
High susceptibility of human c-Ha-ras proto-oncogene transgenic rats to carcinogenesis: a cancer-prone animal model.
15958052
2005
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Mammary Neoplasms
0.450
Biomarker
CTD_human
Frequent mutations of the Trp53, Hras1 and beta-catenin (Catnb) genes in 1,3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice.
12165863
2002
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
NEVUS, EPIDERMAL (disorder)
0.420
Biomarker
CTD_human
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Carcinoma
0.400
Biomarker
CTD_human
Single-strand conformation polymorphism (SSCP) analysis and direct sequencing demonstrated a G-->A transition at the second position of Ha-ras codon 12, with the resultant substitution of glutamic acid for glycine, in two of 10 carcinomas induced by 100 ppm PhIP and in one of seven induced by the 400 ppm dose.
8185828
1994
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Adenoid Cystic Carcinoma
0.400
Biomarker
CTD_human
The mutational landscape of adenoid cystic carcinoma.
23685749
2013
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Malignant neoplasm of lung
0.400
Biomarker
CTD_human
Susceptibilities of p53 knockout and rasH2 transgenic mice to urethane-induced lung carcinogenesis are inherited from their original strains.
15902970
2005
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
Malignant neoplasm of lung
0.400
Biomarker
CTD_human
Mutation analysis of vinyl carbamate or urethane induced lung tumors in rasH2 transgenic mice.
12765245
2003